Key facts
- This page summarizes Mary Beth Harler's Form 4 filing for IGM Biosciences, Inc. (IGMS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Oct 2024, 18:23.
Mary Beth Harler - 02 Oct 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- IGMS
- Reported as of
- 02 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2024, 18:23:34 UTC
- Prior SEC filing
- 17 Sep 2024
- Next SEC filing
- 18 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Misbah Tahir, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mary Beth Harler filed Form 4 for IGM Biosciences, Inc. (IGMS) on 04 Oct 2024.
Change
- Previous filing in this sequence was filed on 17 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IGMS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +185,000
- Change %
- +113%
- Price
- $0.000000
- Shares after
- 348,740
- Date
- 02 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IGMS
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +370,000
- Change %
- Price
- $0.000000
- Shares after
- 370,000
- Date
- 02 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 370,000
- Exercise price
- $14.40
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-third of the RSUs shall vest on November 12, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
Footnote F2
1/48th of the shares subject to the option shall vest on October 30, 2024 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.